1. Home
  2. ASMB vs PHUN Comparison

ASMB vs PHUN Comparison

Compare ASMB & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$19.68

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo Phunware Inc.

PHUN

Phunware Inc.

HOLD

Current Price

$1.97

Market Cap

42.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
PHUN
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
42.6M
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
ASMB
PHUN
Price
$19.68
$1.97
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $52.00
N/A
AVG Volume (30 Days)
★ 195.8K
67.6K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 91.78
39.36
EPS
N/A
★ N/A
Revenue
N/A
★ $30,883,000.00
Revenue This Year
N/A
$37.21
Revenue Next Year
N/A
$1,931.97
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 15.57
52 Week Low
$19.94
$1.56
52 Week High
$39.71
$2.84

Technical Indicators

Market Signals
Indicator
ASMB
PHUN
Relative Strength Index (RSI) 29.78 41.61
Support Level N/A $1.62
Resistance Level $30.36 $2.00
Average True Range (ATR) 1.13 0.06
MACD 0.10 -0.01
Stochastic Oscillator 11.26 5.26

Price Performance

Historical Comparison
ASMB
PHUN

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.

Share on Social Networks: